Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium + Olodaterol FDC vs Components in COPD (TOnado 2)
NCT01431287Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 24
01
Overview
A Phase 3 trial of tiotropium, olodaterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Sep 2011; status: completed.
02
Drugs
tiotropiumolodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01431287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01431287.